This meta-analysis synthesized data from 46 studies to evaluate the relationship between hypothyroidism, subclinical hypothyroidism, and various kidney outcomes. The scope included assessments of chronic kidney disease (CKD) prevalence, eGFR reduction, CKD incidence, and end-stage renal disease (ESRD) in patients with underlying kidney dysfunction.
The analysis identified a significant association between non-distinct hypothyroidism and an increased prevalence of CKD (OR 1.94, 95% CI [1.62, 2.32]). Similarly, subclinical hypothyroidism was significantly associated with increased CKD prevalence (OR 1.87, 95% CI [1.55, 2.27]). Regarding kidney function, a significant reduction in eGFR was observed in non-distinct hypothyroidism (SMD -0.68, 95% CI [-0.81, -0.55]) and subclinical hypothyroidism (SMD -0.99, 95% CI [-1.59, -0.38]).
However, the meta-analysis found no significant association with CKD incidence or ESRD in patients with underlying kidney dysfunction. Furthermore, no significant eGFR improvement was observed following levothyroxine treatment in either non-distinct hypothyroidism or subclinical hypothyroidism.
Authors noted that the association between hypothyroidism and CKD prevalence is cross-sectional, and no definitive prospective association was found. The bidirectional causal association remains controversial. More large-scale randomized controlled trials are needed to supplement this evidence to avoid overtreatment or undertreatment in clinical practice.
View Original Abstract ↓
ObjectiveRegarding the exact association between hypothyroidism, levothyroxine replacement and kidney dysfunction, there is a lack of study to summarize the previous evidence. The aim of this study is to explore these relationships.MethodsThe PubMed, Cochrane Library, EMBASE, and Google Scholar were searched for observational studies and RCTs. The included studies were conducted in adult nonpregnant participants and analyzed kidney outcomes of interest in serologically confirmed hypothyroidism patients. Additionally, studies that examined kidney outcomes during levothyroxine treatment were retrieved. Standard Mean Difference (SMD), Odds Ratios (ORs) and Risk Ratios (RRs) were estimated as the effect variables.ResultsTotally, 46 studies were included. Both non-distinct hypothyroidism and subclinical hypothyroidism (SHypo) were significantly associated with the prevalence of chronic kidney disease (CKD) (OR 1.94, 95% CI [1.62, 2.32]) (OR 1.87, 95% CI [1.55, 2.27]). Non-distinct hypothyroidism and SHypo were also associated with estimated glomerular filtration rate (eGFR) reduction (SMD -0.68, 95% CI [-0.81, -0.55]) (SMD -0.99, 95% CI [-1.59, -0.38]). No significant association between hypothyroidism and CKD incidence was found, and its association with end-stage renal disease (ESRD) was not significant in patients with underlying kidney dysfunction. No significant improvement in eGFR was observed after levothyroxine treatment, either in non-distinct hypothyroidism or in SHypo patients.ConclusionThis study verifies a cross-sectional association between hypothyroidism and kidney dysfunction. However, no definitive prospective association was found. The bidirectional causal association between hypothyroidism, levothyroxine replacement and kidney outcomes remain controversial based on evidence from extensive observational studies. More large-scale randomized controlled trials are needed to supplement this evidence in practice to avoid overtreatment or undertreatment.ResponseThe registraton information has been mentioned in the Methods section.